State-level compounding resources

• State Compounding Legislation and Regulation Tracker (PFM Member Only)
• Compilation of State-Adopted USP 795, 797, and 800 Rules
• Compounding for Office Use and Veterinary Office Use
• Prescriber Briefs (PFM Member Only)

Here are two organizations’ tracking resources on state laws and regulation on e-prescribing. Both give the same info, just the interfaces are different.

The Alliance for Pharmacy Compounding is the voice for pharmacy compounding, representing compounding pharmacists and technicians in both traditional and outsourcing settings, as well as prescribers, educators, patients, and suppliers.

From Surescripts: EPCS Readiness: Which States Lead the Charge?

From MD Toolbox: E-Prescribing Mandate State Laws

Join our coalition of compounders who’ve volunteered to be APC’s eyes and ears and voice at their state’s board of pharmacy meetings. We’re working to have coverage in all 50 states, with at least three volunteers in each state to share the duties and assure consistent coverage of meetings.

When we know what’s going on in your state, we can prepare you with information and talking points to effectively represent your profession.

Interested?

Unfortunately, there are still practitioners out there who question the legitimacy of pharmacy compounding, so they’re reluctant to consider the compounded therapies you can provide their patients. (Or worse, they ask you to compound substances that are prohibited.)

To help you educate your prescribers, APC and the Pharmacy Compounding Foundation have developed five member-only briefing documents you can share with practitioners and other medical professionals:

	The Truth About Pharmacy Compounding, which explains the regulatory framework under which compounders operate and provides an overview of what can and cannot be compounded under federal law.
	Compounding Peptides: It’s Complicated. This briefing explains restrictions on peptide compounding as well as uncertainty surrounding the list of semaglutide on FDA’s Drug Shortage List. An updated briefing will be available soon.
	Prescription Compliance: DEA’s “Wet Signature” Requirement. This briefing explains how the Drug Enforcement Agency’s (DEA) “wet signature” requirement applies to electronic prescriptions for controlled substances.
	Documenting Medical Rationale. With enforcement of FDA’s GFI 256 set to commence April 1, 2023, APC has developed this briefing to help you coach the veterinarians you work with on what they must document on prescriptions for compounded animal drugs.
	Compounding for Racehorses: An Overview for Veterinarians. As a tightly regulated sport, horseracing has specific rules and regulations regarding the use of drugs in horses, including the use of compounded ones.